Allspring Global Investments Holdings LLC cut its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 54.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,543 shares of the medical instruments supplier’s stock after selling 72,498 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.24% of ICU Medical worth $9,407,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp lifted its position in ICU Medical by 9.3% in the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock valued at $165,384,000 after acquiring an additional 77,506 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of ICU Medical by 9.6% during the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock valued at $99,687,000 after buying an additional 48,106 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in shares of ICU Medical by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after buying an additional 27,927 shares during the period. WCM Investment Management LLC lifted its holdings in shares of ICU Medical by 1.3% during the 3rd quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier’s stock valued at $45,272,000 after buying an additional 3,407 shares during the period. Finally, Victory Capital Management Inc. lifted its holdings in shares of ICU Medical by 0.5% during the 3rd quarter. Victory Capital Management Inc. now owns 142,535 shares of the medical instruments supplier’s stock valued at $25,973,000 after buying an additional 687 shares during the period. 96.10% of the stock is owned by institutional investors.
ICU Medical Trading Up 2.0 %
Shares of ICUI stock opened at $163.44 on Wednesday. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of -35.76 and a beta of 0.63. ICU Medical, Inc. has a 12-month low of $93.36 and a 12-month high of $196.26. The stock’s 50-day moving average price is $160.91 and its 200-day moving average price is $165.38.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on ICUI
Insider Transactions at ICU Medical
In other news, COO Christian B. Voigtlander sold 1,430 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director David C. Greenberg sold 972 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the sale, the director now owns 5,037 shares of the company’s stock, valued at $796,400.07. The trade was a 16.18 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 17,737 shares of company stock valued at $2,879,752 in the last ninety days. Corporate insiders own 6.70% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Recommended Stories
- Five stocks we like better than ICU Medical
- What is the Dow Jones Industrial Average (DJIA)?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Evaluate a Stock Before Buying
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.